China approves 1st new drug for Alzheimer’s disease in 17 years

By Julie Zaugg and Jared Peng Authorities in China have approved a drug for the treatment of Alzheimer’s disease, the first new medicine with the potential to treat the cognitive disorder in 17 years. The seaweed-based drug, called Oligomannate, can be used for the treatment of mild to moderate Alzheimer’s, according to a statement fromContinue reading “China approves 1st new drug for Alzheimer’s disease in 17 years”